This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Type 1 Diabetes Mellitus With Hypoglycemia, Impaired Awareness of Hypoglycemia or Type1diabetes
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

This clinical study proposes to assess the impact of Libre on frequency, duration and severity of hypoglycaemia, compared with the Dexcom G5 realtime CGM and will focus on people with impaired awareness of hypoglycaemia.

Provided treatments

  • Device: Dexcom G5 Continuous Glucose Monitor
  • Device: Abbott Freestyle Libre

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03028220. The sponsor of the trial is Imperial College London and it is looking for 40 volunteers for the current phase.
Official trial title:
Impact on Hypoglycaemia Awareness of Real Time CGM and Intermittent Continuous